Usui H - Search Results

1

A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.

Okonogi N, Murata K, Yamada S, Habu Y, Hori M, Kurokawa T, Inaba Y, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Koto M, Hasegawa S, Ishikawa H, Hanaoka H, Shozu M, Tsuji H, Usui H. Okonogi N, et al. Among authors: usui h. Int J Mol Sci. 2023 Jun 23;24(13):10565. doi: 10.3390/ijms241310565. Int J Mol Sci. 2023. PMID: 37445743 Free PMC article. Clinical Trial.

2

Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

Furuya M, Suyama T, Usui H, Kasuya Y, Nishiyama M, Tanaka N, Ishiwata I, Nagai Y, Shozu M, Kimura S. Furuya M, et al. Among authors: usui h. Hum Pathol. 2007 Nov;38(11):1676-87. doi: 10.1016/j.humpath.2007.03.023. Epub 2007 Aug 17. Hum Pathol. 2007. PMID: 17707463

3

Serum YKL-40 as a marker for cervical adenocarcinoma.

Mitsuhashi A, Matsui H, Usui H, Nagai Y, Tate S, Unno Y, Hirashiki K, Seki K, Shozu M. Mitsuhashi A, et al. Among authors: usui h. Ann Oncol. 2009 Jan;20(1):71-7. doi: 10.1093/annonc/mdn552. Epub 2008 Aug 22. Ann Oncol. 2009. PMID: 18723551 Free article.

4

The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.

Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, Mitsuhashi A, Matsui H, Shozu M. Baasanjav B, et al. Among authors: usui h. Hum Reprod. 2010 May;25(5):1183-91. doi: 10.1093/humrep/deq052. Epub 2010 Mar 5. Hum Reprod. 2010. PMID: 20208060

5

Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer.

Mitsuhashi A, Uno T, Usui H, Tate S, Hirashiki K, Kato K, Kiyohara H, Kato S, Ito H, Shozu M. Mitsuhashi A, et al. Among authors: usui h. Anticancer Res. 2010 Jun;30(6):2341-6. Anticancer Res. 2010. PMID: 20651390

6

Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.

Matsui H, Kihara M, Usui H, Tate S, Mitsuhashi A, Shozu M. Matsui H, et al. Among authors: usui h. J Reprod Med. 2009 Oct;54(10):631-5. J Reprod Med. 2009. PMID: 20677483

7

Molecular distinction of consecutive molar pregnancies.

Usui H, Kaku H, Kihara M, Shozu M. Usui H, et al. Obstet Gynecol. 2011 Feb;117(2 Pt 2):492-495. doi: 10.1097/AOG.0b013e318205636b. Obstet Gynecol. 2011. PMID: 21252801

8

The application of a newly developed linear stapler preloaded with tissue reinforcement for distal pancreatectomy in the management of ovarian cancer.

Kato K, Tate S, Uehara T, Usui H, Mitsuhashi A, Shozu M. Kato K, et al. Among authors: usui h. Eur J Gynaecol Oncol. 2011;32(5):579-81. Eur J Gynaecol Oncol. 2011. PMID: 22053681

9

Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.

Kizaki S, Matsui H, Usui H, Shozu M, Hanawa S, Yamamoto E, Kikkawa F. Kizaki S, et al. Among authors: usui h. J Reprod Med. 2012 May-Jun;57(5-6):243-8. J Reprod Med. 2012. PMID: 22696820

10

Complicating preeclampsia as a predictor of poor survival of the fetus in complete hydatidiform mole coexistent with twin fetus.

Kihara M, Usui H, Tanaka H, Inoue H, Matsui H, Shozu M. Kihara M, et al. Among authors: usui h. J Reprod Med. 2012 Jul-Aug;57(7-8):325-8. J Reprod Med. 2012. PMID: 22838249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page